摘要
目的分析涂阳肺结核病人的化疗效果.方法采用两阶段全程间歇的短程化疗方案,对初复治涂阳病人实施全程督导管理,完成疗程后判定疗效.结果1992～2001涂阳肺结核病人登记率由1.5/10万上升到31.58/10万;初治涂阳病人治愈率由11.11%上升到97.25%,复治涂阳病人治愈率由36.84%上升到93.20%.结论合理的化疗方案,全面落实全程督导管理,保证病人规则用药,是提高治愈率的关键.
Objective To analyze the treatment effects of smear-positive cases with pulmonary tuberculosis.Methods Smear-positive pulmonary tuberculosis was treated with the short-course chemotherapy regimens, which was confirmed effective after the treatment. Results From 1992 to 2001, the notification rate of smear positive cases increased from 1.5 to 31.58 per hundred thousand. The cure rate of new smear-positive cases increased from 11.11% to 97.25% and the cure rate of retreatment cases rate ranged between 36.84% and 93.2%.Conclusion In order to improve the effectiveness of the chemotherapy, optimal chemotherapy regimens must be adopted and DOTS must be implemented.
出处
《临床肺科杂志》
2005年第5期612-614,共3页
Journal of Clinical Pulmonary Medicine
